Related Experiment Videos
Acute generalized exanthematous pustulosis associated with pseudoephedrine
M A Padial1, J Alvarez-Ferreira, B Tapia
1Department of Allergy, Hospital Universitario La Paz, P degrees Castellana 261, 28046 Madrid, Spain.
The British Journal of Dermatology
|January 30, 2004
Summary
Acute generalized exanthematous pustulosis (AGEP), a rare drug-induced skin reaction, was characterized in a patient exposed to pseudoephedrine. The study confirmed pseudoephedrine as the cause and identified key immune responses involved in AGEP.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Acute generalized exanthematous pustulosis (AGEP) is an uncommon, severe cutaneous adverse drug reaction.
- Drug-specific T-cell responses and interleukin-8 (IL-8) production are implicated in AGEP pathogenesis.
- Adverse reactions to sympathomimetic drugs, like pseudoephedrine, are rarely reported in AGEP.
Observation:
- A case of AGEP clinically and immunologically characterized following pseudoephedrine exposure.
- Histological examination of skin biopsies confirmed AGEP.
- Epicutaneous testing confirmed pseudoephedrine as the specific causative agent.
Findings:
- Immunohistochemistry revealed a skin infiltrate of activated memory T cells and polymorphonuclear cells.
- Reverse transcription-polymerase chain reaction demonstrated elevated IL-8 expression in affected skin.
- These findings support the role of drug-specific T cells and IL-8 in pseudoephedrine-induced AGEP.
Implications:
- This study highlights pseudoephedrine as a potential trigger for AGEP.
- It provides further evidence for the immunological mechanisms underlying AGEP, involving T cells and IL-8.
- Understanding these mechanisms can aid in diagnosing and managing AGEP and other severe cutaneous adverse drug reactions.